The Effects of Fish Oil on Patients With Chronic Nonspecific Low Back Pain

Status Completed

Clinical Trial Summary

Objectives:

To investigate the efficacy of omega-3 polyunsaturated fatty acids (PUFA) on patients with chronic nonspecific low back pain (NLBP).

Methods and Materials:

Twenty-nine patients with chronic NLBP were randomly divided into experimental and control groups. For 8 weeks, participants in the experimental group received omega-3 PUFA at 3000 mg/day plus physical therapy, while those in the control group received placebo plus physical therapy. The visual analog pain scale, pressure algometer, Biering-Sorenson test, Roland-Morris Low Back Pain and Disability Questionnaire (RMQ), and occupational burnout inventory (OBI) were used in assessments at baseline (T0) and after 4 (T1) and 8 weeks (T2). Serum erythrocyte sedimentation rate (ESR) and hypersensitive C-reactive protein (hs-CRP) were checked at baseline and T2.

Clinical Trial Description

Low back pain is a common symptom in modern society. However, nearly 85% of those who seek medical care for low back pain have no specific history and no specific finding in image study, and therefore do not receive a specific diagnosis. This type of low back pain is termed "nonspecific low back pain." Fish oil contains omega-3 polyunsaturated fatty acid, including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). EPA and DHA can reduce the synthesis of prostaglandin E2. They are also the precursors of the E-resolvin and D-resolvin that suppress inflammatory cytokine production and act to resolve inflammation. Several previous studies showed that fish oil has the effect of anti-inflammation and pain reduction without side effect that affecting stomach and renal function. Therefore, fish oil is considered a new type of NSAID, and many studies are investigating its effect of anti-inflammation and pain reduction on different diseases. The purpose of this study is to investigate the effects of fish oil on patients with chronic nonspecific low back pain. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02774109
Study type	Interventional
Source	Chang Gung Memorial Hospital
Contact
Status	Completed
Phase	N/A
Start date	December 2016
Completion date	November 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03243084` - Transcranial Alternating Current Stimulation in Back Pain- Pilot Sudy	N/A
Suspended	`NCT04735185` - Stem Cells vs. Steroids for Discogenic Back Pain	N/A
Completed	`NCT03162952` - RAND Center of Excellence for the Study of Appropriateness of Care in CAM
Completed	`NCT03240146` - Pulsed Shortwave Therapy Treatment for Chronic Musculoskeletal Low Back Pain	N/A
Completed	`NCT05282589` - Lumbopelvic Manipulation Effects on Fatigue in Chronic Low Back Pain Patients	N/A
Completed	`NCT03637998` - Physical Activity on Neurophysiologic Gene Expression Profiles of Chronic Low Back Pain	N/A
Recruiting	`NCT02289170` - Clinical Study to Evaluate the Safety and Efficacy of Heating and Cooling Combination Therapeutic Device(OCH-S100)	N/A
Active, not recruiting	`NCT01944163` - The IMPACT of a Referral Model for Axial Spondyloarthritis in Young Patients With Chronic Low Back Pain	N/A
Completed	`NCT02231554` - Feldenkrais vs Back School for Treating Chronic Low Back Pain: a Randomized Controlled Trial	N/A
Recruiting	`NCT02063503` - Identification of Prognostic Indicators for Rehabilitation in Chronic Nonspecific Low Back Pain Patients	N/A
Completed	`NCT01704677` - Lumbar Disc Prosthesis Versus Multidisciplinary Rehabilitation; 8-year Follow-up	N/A
Terminated	`NCT01620775` - MR(Magnetic Resonance) Imaging of Neurotransmitters in Chronic Pain	N/A
Completed	`NCT01177254` - Exposure to Potential Cytochrome P450 Pharmacokinetic Drug-Drug Interactions Among Osteoarthritis Patients: Incremental Risk of Multiple Prescriptions	N/A
Completed	`NCT01490905` - A Double Blind Placebo Study to Determine the Effectiveness of Theramine on the Management of Chronic Back Pain	Phase 4
Completed	`NCT01177280` - Prevalence of Potential Cytochrome P450 Pharmacokinetic Incident Drug-Drug Interactions Among Chronic Low Back Pain Patients Taking Opioid Analgesics and Associated Economic Outcomes	N/A
Completed	`NCT01177241` - Cytochrome P450 Pharmacokinetic DDIs Among Patients With Chronic Low Back Pain Taking Opioids	N/A
Completed	`NCT00984815` - Safety Study of HZT-501 in Patients Who Require Long-Term Daily Non-steroidal Anti-inflammatory Drug Treatment	Phase 3
Completed	`NCT00763321` - Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)	Phase 3
Completed	`NCT00761150` - Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)	Phase 3
Completed	`NCT00767806` - A Study for Patient With Chronic Low Back Pain	Phase 3